|Last Price$18.29||Day Change (%)-2.04%|
|Open Price$18.57||Day Change ($)-0.38|
|Day Range18.24–18.67||52-Week Range16.06–19.05|
As of Fri 4/17/2015 5:02:00 PM | USD
Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting
BNC105 Biomarker Data to Be Presented at Asian Oncology Conference
SilverCrest Announces Update to Santa Elena Pre-Feasibility Study; Pre-Tax Base Case NPV (5%) of $144 Million, Replaces Reserves and Renews 8 Year Mine Life
Lifshitz & Miller Law Firm Announces Investigation of Accelerate Diagnostics, Inc., Adamis Pharmaceuticals Corporation, Aerohive Networks, Inc., Boulder Brands, Inc., Dynamic Materials Corporation and SanDisk Corp.
Burzynski Research Institute, Inc. Announces Publication of Phase II Results in Adults with Newly-Diagnosed Anaplastic Astrocytoma
Cerulean Reports Fourth Quarter 2014 Corporate Highlights and Financial Results
A curious move, at a curious time, for purportedly, a curious reason, that is also a slap in the face to CPAs with the PFS credential.
This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...
To the extent that this content includes references to securities, those references do not constitute an offer or solicitation to buy, sell or hold such security. AdvisorShares is a sponsor of actively managed exchange-traded funds (ETFs) and holds positions in all of its ETFs. This document should ...
Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus. Please read the prospectus carefully before you invest. Foreside Fund Services, LLC, Distributor. An investment in the Funds is subject to ...